Uwe Liebelt, the esteemed plant manager of BASF's Ludwigshafen facility, is set to leave his position effective July 1, 2025, as the company announces a significant transition. This decision, made at Liebelt's own request and in mutual agreement with BASF, marks the end of a pivotal chapter for both the manager and the global chemical giant.
Since joining BASF in 1996 as a chemical engineer, Liebelt has played an instrumental role in the company, particularly as the head of the Ludwigshafen main plant since 2016. Under his leadership, the facility has not only maintained its status as a cornerstone of BASF's European operations but has also enhanced its standing within the community and the chemical industry at large. His profound contributions during this period have been recognized widely, making his impending departure all the more noteworthy.
On March 25, 2025, BASF officially announced Liebelt's decision, confirming that he will dedicate his efforts to his start-up company in brain tumor research, which is a field that holds personal significance for him. The announcement underscored that Liebelt will also step down from various honorary positions, including Vice President of the IHK Pfalz and as the chairman of the Zukunft Metropolregion Rhein-Neckar association, in order to fully focus on his new venture.
Reflecting on his decision, Liebelt stated, "His departure is at his own request and by mutual agreement." This acknowledgment highlights the respect he has earned within the company and the community, as well as the understanding of his aspirations. His forthcoming move into the realm of medical research signifies a substantial shift from his industrial roots, aiming to make a meaningful impact in addressing critical health issues.
In the interim, Helmut Winterling, who is currently the head of research for BASF, will succeed Liebelt as President European Site & Verbund Management, beginning the same day as Liebelt's departure. At 54, Winterling brings a deep understanding of BASF's operations, having joined the company in 1999 after earning a degree in chemistry. His experience is expected to lend continuity to the leadership at Ludwigshafen and beyond, maintaining the innovative spirit that Liebelt fostered.
As Liebelt prepares for this new chapter, he leaves behind a legacy characterized by a commitment to sustainability, innovation, and community engagement which has set a high standard within BASF. His leadership has not only driven the company’s operational excellence but has also strengthened its bond with the communities it serves, highlighting the importance of corporate responsibility in today's business landscape.
Looking ahead, the focus will be on how Winterling will navigate the challenges and opportunities that lie ahead for BASF, particularly in light of evolving industry demands and the ongoing push for sustainable practices within the chemical sector. As Liebelt concludes his time at BASF, the transition exemplifies the dynamic nature of corporate leadership and the personal journeys that often accompany professional changes.
The community and colleagues alike are sure to feel the impact of Liebelt's departure, as he has been a pivotal figure in shaping BASF’s direction. As he embarks on a brave new endeavor in brain tumor research, many will be watching closely to see how his experiences in the corporate world translate into the health sector, where innovation and research are crucial.
